BIIB Projected Dividend Yield
Biogen Inc ( NASDAQ : BIIB )Biogen Inc. is a biopharmaceutical company dedicated to developing advanced therapies for serious diseases. Its portfolio includes treatments for multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Key products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for MS; SPINRAZA for SMA; SKYCLARYS for Friedreich's Ataxia; QALSODY for ALS; and FUMADERM for severe plaque psoriasis. Co. also collaborates on LEQEMBI, ZURZUVAE, RITUXAN, GAZYVA, OCREVUS, LUNSUMIO and COLUMVI, and commercializes biosimilars such as BENEPALI, IMRALDI, FLIXABI and BYOOVIZ. 21 YEAR PERFORMANCE RESULTS |
BIIB Dividend History Detail BIIB Dividend News BIIB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |